Heidi Roschitzki‐Voser
Heidi Roschitzki‐Voser publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Lung Cancer Diagnosis and Treatment.
- World rank
- #770,565 of 7,710,434 ranked researchers
- Rank in Greece
- #2,922 of 33,280
- Works
- 45
- Citations
- 2k
- Citations per work
- 43.6
What does Heidi Roschitzki‐Voser research?
Heidi Roschitzki‐Voser's work is mostly in Medicine (73%), Biochemistry, Genetics and Molecular Biology (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3372.6%
- Medicine3372.6%
- Life Sciences714.8%
- Everything else612.6%
- 1Pulmonary and Respiratory Medicine37% of their works
- 2Oncology30% of their works
- 3Molecular Biology12% of their works
- 4Radiology, Nuclear Medicine and Imaging3% of their works
- 5Surgery2% of their works
- 6Cell Biology2% of their works
Research topics
Which keywords describe Heidi Roschitzki‐Voser's research?
The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Immunotherapy, CT Screening and Immune Checkpoint Blockade.
- Pleural Effusion
- Empyema
- Malignant Pleural Mesothelioma
- KRAS Mutations
- Small-Cell Lung Cancer
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Immunotherapy
- ALK Inhibitors
- Clinical Trials
- Chemotherapy
- Targeted Therapy
- EGFR Mutations
- CT Screening
- Lung Cancer
- Genomic Profiles
- Cetuximab
- BAP1 mutations
- Breast Cancer
- HER2
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Chemotherapy334 topics
- Clinical Trials282 topics
- Targeted Therapy282 topics
- ALK Inhibitors171 topic
- EGFR Mutations171 topic
- Immunotherapy162 topics
- CT Screening121 topic
- Immune Checkpoint Blockade121 topic
- Lung Cancer121 topic
- PD-1 and PD-L1121 topic
- Genomic Profiles111 topic
- Small-Cell Lung Cancer111 topic
- Cetuximab61 topic
- KRAS Mutations61 topic
- BAP1 mutations51 topic
- Malignant Pleural Mesothelioma51 topic
- Breast Cancer41 topic
- Empyema41 topic
- HER241 topic
- Pleural Effusion41 topic
Where does Heidi Roschitzki‐Voser work?
Heidi Roschitzki‐Voser's main affiliation in the publication record is Frontier Science Foundation-Hellas, Greece.
How many publications and citations does Heidi Roschitzki‐Voser have?
OpenAlex counts 45 works and 1,960 citations for Heidi Roschitzki‐Voser, an h-index of 20, ranking #770,565 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Heidi Roschitzki‐Voser. Posts are plain text and can be reported.